197 related articles for article (PubMed ID: 11803287)
1. A case of primary cutaneous CD56+, TdT+, CD4+, blastic NK-cell lymphoma in a 19-year-old woman.
Chang SE; Choi HJ; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
Am J Dermatopathol; 2002 Feb; 24(1):72-5. PubMed ID: 11803287
[TBL] [Abstract][Full Text] [Related]
2. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
[TBL] [Abstract][Full Text] [Related]
3. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
4. [Agranular CD4+ CD56+ CD123+ hematodermic neoplasm (blastic NK-cell lymphoma) revealed by cutaneous localization: 2 cases].
Machet L; De Muret A; Wiezberka E; Bernez A; Abdallah-Lotf M; Linassier C; Petrella T
Ann Dermatol Venereol; 2004 Nov; 131(11):969-73. PubMed ID: 15602384
[TBL] [Abstract][Full Text] [Related]
5. Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement.
Liu XY; Atkins RC; Feusner JH; Rowland JM
Am J Hematol; 2004 Apr; 75(4):251-3. PubMed ID: 15054822
[TBL] [Abstract][Full Text] [Related]
6. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
[TBL] [Abstract][Full Text] [Related]
7. Agranular CD4+CD56+ blastic natural killer leukemia/lymphoma.
Kimura S; Kakazu N; Kuroda J; Akaogi T; Hayashi H; Nishida K; Abe T
Ann Hematol; 2001 Apr; 80(4):228-31. PubMed ID: 11401089
[TBL] [Abstract][Full Text] [Related]
8. Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UK.
Child FJ; Mitchell TJ; Whittaker SJ; Calonje E; Spittle M; Crocker J; Russell-Jones R
Br J Dermatol; 2003 Mar; 148(3):507-15. PubMed ID: 12653743
[TBL] [Abstract][Full Text] [Related]
9. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
[TBL] [Abstract][Full Text] [Related]
10. Blastic CD56+ natural killer-cell lymphoma with primary cutaneous manifestation.
Berger TG; Voll RE; Simon M; Kiesewetter F
Acta Derm Venereol; 2004; 84(1):53-6. PubMed ID: 15040479
[TBL] [Abstract][Full Text] [Related]
11. Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity.
Koita H; Suzumiya J; Ohshima K; Takeshita M; Kimura N; Kikuchi M; Koono M
Am J Surg Pathol; 1997 Feb; 21(2):242-8. PubMed ID: 9042293
[TBL] [Abstract][Full Text] [Related]
12. [Retrospective analysis of 4 cases of the so-called blastic NK-cell lymphoma, with reference to the 2008 WHO classification of tumours of haematopoietic and lymphoid tissues].
Zheng YY; Chen G; Zhou XG; Jin Y; Xie JL; Zhang SH; Zhang YN
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):600-5. PubMed ID: 21092587
[TBL] [Abstract][Full Text] [Related]
13. [Hematodermic CD4/CD56 neoplasm].
Petrella T; Wechsler J; Courville P; de Muret A; Bosq J; Déchelotte P; Feuillard J; Durlach A; Vergier B
Ann Pathol; 2004 Jun; 24(3):241-55; quiz 227. PubMed ID: 15480259
[TBL] [Abstract][Full Text] [Related]
14. Agranular CD4+/CD56+ cutaneous neoplasm.
Touahri T; Belaouni H; Mossafa H; Pulik M; Bourguigna L; Ibbora C; Dal Soglio D; Davi F; Fourcade C
Leuk Lymphoma; 2002 Jul; 43(7):1475-9. PubMed ID: 12389632
[TBL] [Abstract][Full Text] [Related]
15. CD2-, CD4+, CD56+ agranular natural killer cell lymphoma of the skin.
Uchiyama N; Ito K; Kawai K; Sakamoto F; Takaki M; Ito M
Am J Dermatopathol; 1998 Oct; 20(5):513-7. PubMed ID: 9790118
[TBL] [Abstract][Full Text] [Related]
16. Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification.
Karube K; Ohshima K; Tsuchiya T; Yamaguchi T; Suefuji H; Suzumiya J; Harada M; Kikuchi M
Am J Surg Pathol; 2003 Oct; 27(10):1366-74. PubMed ID: 14508398
[TBL] [Abstract][Full Text] [Related]
17. A case of cutaneous blastic NK lymphoma in a 32-year-old Korean woman.
Chang SE; Choi HJ; Huh J; Choi JH; Moon KC; Koh JK
Int J Dermatol; 2006 May; 45(5):591-3. PubMed ID: 16700799
[No Abstract] [Full Text] [Related]
18. T-cell/natural killer cell lymphoblastic lymphoma with an unusual coexpression of B-cell antigens.
Gloeckner-Hofmann K; Ottesen K; Schmidt S; Nizze H; Feller AC; Merz H
Ann Hematol; 2000 Nov; 79(11):635-9. PubMed ID: 11131924
[TBL] [Abstract][Full Text] [Related]
19. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes.
Petrella T; Comeau MR; Maynadié M; Couillault G; De Muret A; Maliszewski CR; Dalac S; Durlach A; Galibert L
Am J Surg Pathol; 2002 Jul; 26(7):852-62. PubMed ID: 12131152
[TBL] [Abstract][Full Text] [Related]
20. CD56 and terminal deoxynucleotidyl transferase positive cutaneous lymphoblastic lymphoma.
Amo Y; Yonemoto K; Ohkawa T; Sasaki M; Isobe Y; Sugimoto K; Katsuoka K
Br J Dermatol; 2000 Sep; 143(3):666-8. PubMed ID: 10971362
[No Abstract] [Full Text] [Related]
[Next] [New Search]
